- Home
- ORI vs PEN Comparison
ORI vs PEN Comparison
Compare ORI & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORI
- PEN
- Stock Information
- Founded
- ORI 1923
- PEN 2004
- Country
- ORI United States
- PEN United States
- Employees
- ORI N/A
- PEN N/A
- Industry
- ORI Property-Casualty Insurers
- PEN Medical/Dental Instruments
- Sector
- ORI Finance
- PEN Health Care
- Exchange
- ORI Nasdaq
- PEN Nasdaq
- Market Cap
- ORI 10.8B
- PEN 10.9B
- IPO Year
- ORI N/A
- PEN 2015
- Fundamental
- Price
- ORI $46.56
- PEN $297.62
- Analyst Decision
- ORI Strong Buy
- PEN Strong Buy
- Analyst Count
- ORI 2
- PEN 16
- Target Price
- ORI $46.50
- PEN $307.19
- AVG Volume (30 Days)
- ORI 2.0M
- PEN 535.2K
- Earning Date
- ORI 10-23-2025
- PEN 11-05-2025
- Dividend Yield
- ORI 2.50%
- PEN N/A
- EPS Growth
- ORI N/A
- PEN 367.34
- EPS
- ORI 3.32
- PEN 4.14
- Revenue
- ORI $8,748,900,000.00
- PEN $1,333,798,000.00
- Revenue This Year
- ORI $10.22
- PEN $15.52
- Revenue Next Year
- ORI $6.10
- PEN $14.20
- P/E Ratio
- ORI $13.99
- PEN $71.52
- Revenue Growth
- ORI 7.08
- PEN 14.61
- 52 Week Low
- ORI $33.00
- PEN $221.26
- 52 Week High
- ORI $46.63
- PEN $310.00
- Technical
- Relative Strength Index (RSI)
- ORI 72.90
- PEN 71.07
- Support Level
- ORI $40.61
- PEN $276.01
- Resistance Level
- ORI $46.35
- PEN $285.87
- Average True Range (ATR)
- ORI 0.87
- PEN 8.07
- MACD
- ORI 0.42
- PEN 3.06
- Stochastic Oscillator
- ORI 98.51
- PEN 90.97
About ORI Old Republic International Corporation
Old Republic International Corp offers a diverse range of specialized insurance products to individuals and institutions. The company operates in two segments: Specialty Insurance and Title Insurance. The Insurances provided by the company includes Automobile Extended Warranty Insurance, Aviation, Commercial Automobile Insurance, Inland Marine, Travel Accident, Workers' Compensation, Financial Indemnity, and others.
About PEN Penumbra Inc.
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.